Induction of apoptosis of metastatic mammary carcinoma cells invivo by disruption of tumor cell surface CD44 function

Journal of Experimental Medicine

Volumn 186, Issue 12, 1997, Pages 1985-1996

  Yu, Qin ^a,b   Toole, Bryan P ^c   Stamenkovic, Ivan ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; INTERNALIZATION; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD44; APOPTOSIS; FEMALE; HYALURONIC ACID; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED A; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; SOLUBILITY; STROMAL CELLS; SURFACE PROPERTIES; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR ESCAPE;

EID: 0031453690     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.12.1985     Document Type: Article

References (39)

1. Ruoslahti, E., and J.C. Reed. 1994. Anchorage dependence, integrins and apoptosis. Cell. 77:477-478.
2. Hynes, R.O. 1992. Integrins: versatility, modulation and signaling in cell adhesion. Cell. 69:11-25.
3. Juliano, R.L., and J.A. Varner. 1993. Adhesion molecules in cancer: the role of integrins. Curr. Opin. Cell Biol. 5:812-818.
4. Gunthert, U., M. Hofmann, W. Rudy, S. Reber, M. Zoller, I. Haussmann, S. Matzku, A. Wenzel, H. Ponta, and P. Herrlich. 1991. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 65:13-24.
5. Sy, M.-S., Y.-J. Guo, and I. Stamenkovic. 1991. Distinct effects of two CD44 isoforms on tumor growth in vivo. J. Exp. Med. 174:859-866.
6. Sy, M.-S., Y.-J. Guo, and I. Stamenkovic. 1992. Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J. Exp. Mcd. 176:623-627.
7. Lesley, J., J.R. Hyman, and P. Kincade. 1993. CD44 and its interaction with extracellular matrix. Adv. Immunol. 54:271-335.
8. Screaton, G.R., M.V. Bell, D.G. Jackson, F.B. Cornelis, U. Gerth, and J.I. Bell. 1992. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA. 89:12160-12164.
9. Arufo, A., I. Stamenkovic, M. Melnick, C.B. Underhill, and B. Seed. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1303-1313.
10. Miyake, K., C.B. Underhill, J. Lesley, and P.W. Kincade. 1990. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med. 172:69-75.
11. Stamenkovic, I., A. Aruffo, M. Amiot, and B. Seed. 1991. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate bearing cells. EMBO (Eur. Mol. Biol. Organ.) J. 10:343-348.
12. Thomas, L., H.R. Byers, J. Vink, and I. Stamenkovic. 1992. CD44H regulates tumor cell migration on hyaluronate-coated substrate. J. Cell Biol. 118:971-977.
13. Shimizu, Y., G.A. van Seventer, R. Siraganian, L. Wahl, and S. Shaw. 1989. Dual role of the CD44 molecule in T cell adhesion and activation. J. Immunol. 143:2457-2463.
14. Lesley, J., N. Howes, A. Perschl, and R. Hyman. 1994. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J. Exp. Med. 180:383-387.
15. Bennett, K.L., D.G. Jackson, J.C. Simon, E. Tanczos, R. Peach, B. Modrell, I. Stamenkovic, G. Plowman, and A. Aruffo. 1995. CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J. Cell Biol. 128:687-698.
16. Weber, G.F., S. Ashkar, M.J. Glimcher, and H. Cantor. 1996. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science. 271:509-512.
17. Jalkanen, S., and M. Jalkanen. 1992. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J. Cell Biol. 116:817-825.
18. Culty, M., H.A. Nguyen, and C.B. Underhill. 1992. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J. Cell Biol. 116:1055-1062.
19. Hua, Q., C.B. Knudson, and W. Knudson. 1993. Internalization ot hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. J. Cell Sci. 106:365-375.
20. Laurent, T.C., and J.R. Fraser. 1992. Hyaluronan. FASEB Fed. Am. Soc. Exp. Biol.) J. 6:2397-2404.
21. Toole, B.P. 1990. Hyaluronan and its binding proteins, the hyaladherins. Curr. Opin. Cell Biol. 2:839-844.
22. Toole, B.P. 1982. Glycosaminoglycans and morphogenesis. In Cell Biology of the Extracellular Matrix second edition. E. Hay, editor. Plenum Press, New York. pp. 259-294.
23. Bartolazzi, A., R. Peach, A. Aruffo, and I. Stamenkovic. 1994. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J. Exp. Med. 180:53-66.
24. Yu, Q., and B.P. Toole. 1996. A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44. J. Biol. Chem. 271:20603-20607.
25. Green, S.J., G. Tarone, and C.B. Underhill. 1988. Distribution of hyaluronate and hyaluronate receptors in the adult lung. J. Cell Sci. 90:145-156.
26. Peach, R.J., D. Hollenbaugh, I. Stamenkovic, and A. Aruffo. 1993. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol. 122:257-264.
27. Toole, B.P., C. Biswas, and J. Gross. 1979. Hyaluronate and invasiveness of the rabbit V2 carcinoma. Proc. Natl. Acad. Sci. USA. 76:6299-6303.
28. Knudson, W., and B.P. Toole. 1988. Membrane association of the hyaluronate stimulatory factor from LX-1 human lung carcinoma cells. J. Cell Biochem. 38:165-177.
29. Bartolazzi, A., D. Jackson, K. Bennett, A. Aruffo, R. Dickinson, J. Shields, N. Whittle, and I. Stamenkovic. 1995. Regulation of growth and dissemination of a human lymphoma by CD44 splice variants. J. Cell Sci. 108:1723-1733.
30. Katoh, S., J.B. McCarthy, and P.W. Kincaide. 1994. Characterization of soluble CD44 in the circulation of mice. J. Immunol. 153:3440-3449.
31. Guo, Y.-J., G. Liu, X. Wang, D. Jin, M. Wu, J. Ma, and M.-S. Sy. 1994. Potential use of soluble CD44 in serum as an indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res. 54:422-426.
32. Sleeman, J., W. Rudy, M. Hofmann, P. Herrlich, and H. Ponta. 1996. Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J. Cell Biol. 135:1139-1150.
33. Culty, M., M. Shizari, E.W. Thompson, and C.B. Underhill. 1994. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44. J. Cell. Physiol. 160:275-286.
34. Kaya, G., I. Rodriguez, J.L. Jorcano, P. Vassalli, and I. Stamenkovic. 1997. Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev. 11:996-1007.
35. Knudson, W., C. Biswas, X.-Q. Li, R.E. Nemec, and B.P. Toole. 1989. The role and regulation of tumor associated hyaluronan. Ciba Found. Symp. 143:150-170.
36. McKee, C.M., C.J. Lowenstein, M.R. Horton, J. Wu, C. Bao, B.Y. Chin, A.M. Choi, and P.W. Noble. 1997. Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor kβ-dependent mechanism. J. Biol. Chem. 272:8013-8018.
37. Shannon, B.T., S.H. Love, and Q.N. Myrvik. 1980. Participation of hyaluronic acid in the macrophage disappearance reaction. Immunol. Commun. 9:357-370.
38. Meredith, J.E., B. Fazeli, and M.A. Schwartz. 1993. The extracellular matrix as a survival factor. Mol. Biol. Cell. 4:953-961.
39. Frisch, S.M., and H. Francis. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124:619-626.